PRDX1 and liver cancer: However, Ren, Ye et al. reported a “relatively weak expression” of PRX1 in laryngeal cancer (Hep2), liver cancer cell (SUN449) lymphoma leukaemia (KOPN63) and acute lymphoblastic leukaemia (MOLT-4) cell lines [117].